- Home
- EFSC vs HRMY Comparison
EFSC vs HRMY Comparison
Compare EFSC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | HRMY |
|---|---|---|
| Founded | 1988 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EFSC | HRMY |
|---|---|---|
| Price | $54.12 | $37.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $65.67 | $51.33 |
| AVG Volume (30 Days) | 202.6K | ★ 674.4K |
| Earning Date | 01-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | 8.68 | ★ 50.44 |
| EPS | ★ 5.13 | 3.17 |
| Revenue | $646,694,000.00 | ★ $825,944,000.00 |
| Revenue This Year | $20.14 | $23.11 |
| Revenue Next Year | $5.15 | $16.15 |
| P/E Ratio | ★ $10.54 | $11.80 |
| Revenue Growth | 9.31 | ★ 21.13 |
| 52 Week Low | $45.22 | $25.52 |
| 52 Week High | $62.60 | $40.93 |
Technical Indicators
Market Signals| Indicator | EFSC | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 51.88 |
| Support Level | $55.24 | $37.12 |
| Resistance Level | $55.66 | $39.60 |
| Average True Range (ATR) | 0.94 | 1.11 |
| MACD | -0.31 | -0.42 |
| Stochastic Oscillator | 18.16 | 22.37 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.